Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2025-12-25 @ 3:33 AM
NCT ID:
NCT01230905
Eligibility Criteria:
Inclusion Criteria:
Cancer Population:
1. Diagnosis of prostate cancer
2. Treatment group: Scheduled to start AST, at Ottawa Hospital under the care of Radiation Oncology, Urology or Medical Oncology.
Control group: no AST scheduled as a treatment option for prostate cancer.
Non-Cancer Control Group
1. Male with low pre-test likelihood of coronary artery disease
2. No previous history of cancer.
Exclusion Criteria:
1. Known coronary disease including any of previous revascularization, history of myocardial infarction, coronary disease with \>= 50% stenosis in a major coronary vessel on previous angiography, evidence of previous myocardial infarction on 12-lead electrocardiogram, positive myocardial perfusion scan, previous cardiac PET scan, stress echocardiogram or exercise stress test.
2. Subjects with a Summed Stress Score of \>4 attributed to coronary disease on baseline PET images
3. Patients previously treated with AST
4. Patients with a life expectancy of less than 1 year.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01230905
Study Brief:
Protocol Section:
NCT01230905